Reckitt Benckiser Group PLC — Board/Management Information 2019

Mar 5, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9305R

Reckitt Benckiser Group PLC

05 March 2019

5 March 2019

DIRECTORATE CHANGE: MEHMOOD KHAN

Appointment to Board of Life Biosciences Inc.

In accordance with Listing Rule 9.6.14, Reckitt Benckiser Group plc announces that Dr Mehmood Khan, Non-executive Director, has been appointed as Chief Executive of Life Biosciences Inc., a Boston-based biotech company, with effect from 1 April 2019.

For further Information:

Rupert Bondy

Company Secretary

Tel +44 (0) 1753 217 800

Richard Joyce

SVP, Investor Relations

Tel. +44 (0)1753 217 800

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

About RB:

RB* is the global leading consumer health, hygiene and home company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries.  From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's unique culture is at the heart of its success.  Its drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 employees worldwide. 

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNJAMFTMBMMBIL